Frank McEnulty, President and CEO at Cell MedX Corp. (CMXC), bought 40,000 shares at $0.25 ($10K) on 2020-07-30, disclosed to the SEC on 2020-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.